We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns Against Untested MS Treatment, Calls for Rigorous Studies
FDA Warns Against Untested MS Treatment, Calls for Rigorous Studies
May 18, 2012
The FDA is advising physicians and clinical trial sites that may be studying an experimental procedure for multiple sclerosis (MS) that they need to get investigational device exemption (IDE) approval to proceed.